Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Biomarker research in Parkinson's disease: objective measures needed for patient stratification in future cause-directed trials.

× No keyword cloud information.

8 in total

1. Considerations regarding the etiology and future treatment of autosomal recessive versus idiopathic Parkinson disease.

Authors: Tohru Kitada; Julianna J Tomlinson; Hei Sio Ao; David A Grimes; Michael G Schlossmacher
Journal: Curr Treat Options Neurol Date: 2012-06 Impact factor: 3.598

Review 2. Biomarkers of Parkinson's disease: present and future.

Authors: Diane B Miller; James P O'Callaghan
Journal: Metabolism Date: 2014-10-31 Impact factor: 8.694

Review 3. Urate in Parkinson's disease: more than a biomarker?

Authors: Xiqun Chen; Guanhui Wu; Michael A Schwarzschild
Journal: Curr Neurol Neurosci Rep Date: 2012-08 Impact factor: 5.081

4. Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies.

Authors: P G Foulds; O Yokota; A Thurston; Y Davidson; Z Ahmed; J Holton; J C Thompson; H Akiyama; T Arai; M Hasegawa; A Gerhard; D Allsop; D M A Mann
Journal: Neurobiol Dis Date: 2011-08-10 Impact factor: 5.996

5. Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: the P_R EDIGT score.

Authors: Michael G Schlossmacher; Julianna J Tomlinson; Goncalo Santos; Bojan Shutinoski; Earl G Brown; Douglas Manuel; Tiago Mestre
Journal: Eur J Neurosci Date: 2016-12-27 Impact factor: 3.386

6. Commentary: Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Authors: Yassar Alamri; Michael MacAskill; Tim Anderson
Journal: Front Aging Neurosci Date: 2017-01-09 Impact factor: 5.750

7. MicroRNAs from extracellular vesicles as a signature for Parkinson's disease.

Authors: Lucas Caldi Gomes; Anna-Elisa Roser; Gaurav Jain; Tonatiuh Pena Centeno; Fabian Maass; Lukas Schilde; Caroline May; Anja Schneider; Mathias Bähr; Katrin Marcus; André Fischer; Paul Lingor
Journal: Clin Transl Med Date: 2021-04

8. Αlpha-synuclein levels in blood plasma from LRRK2 mutation carriers.

Authors: Ana Gorostidi; Alberto Bergareche; Javier Ruiz-Martínez; José F Martí-Massó; María Cruz; Shiji Varghese; Mohamed M Qureshi; Fatimah Alzahmi; Abdulmonem Al-Hayani; Adolfo López de Munáin; Omar M A El-Agnaf
Journal: PLoS One Date: 2012-12-27 Impact factor: 3.240